V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20210272 | 20174500 | 1.75 | 79.6 | null | 2018-01-04 | 2018-01-12 | Docetaxel | 02 | null | DOCETAXEL | 100620408 |
| 20210285 | 20174501 | 1.85 | null | null | null | 2019-09-02 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100822570 |
| 20210326 | 20174502 | null | 50.8 | Curative (C) | 2022-04-21 | 2022-04-22 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100037464 |
| 20210348 | 20174503 | 1.83 | 74 | null | 2020-02-14 | 2020-02-20 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101018403 |
| 20210431 | 20174504 | 1.84 | 73.5 | null | 2021-04-12 | 2021-04-13 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100019435 |
| 20210463 | 20174505 | 1.8 | 65.3 | Palliative (P) | 2022-04-08 | 2022-04-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101182649 |
| 20210466 | 20174506 | 1.71 | 54.4 | Palliative (P) | 2022-01-16 | 2022-01-19 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101622541 |
| 20210474 | 20174507 | 1.69 | 105 | Palliative (P) | 2016-09-26 | 2016-10-16 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100268827 |
| 20210478 | 20174508 | 1.93 | 87.4 | null | 2020-02-14 | 2020-02-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100316944 |
| 20210493 | 20174509 | 1.76 | 86.3 | null | 2021-07-05 | 2021-07-18 | Docetaxel | 02 | null | DOCETAXEL | 101759679 |
| 20210502 | 20174510 | 1.74 | 73.2 | null | 2021-08-23 | 2021-08-28 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101268671 |
| 20210504 | 20174511 | 1.68 | 88.9 | Palliative (P) | 2021-10-10 | 2021-10-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100560326 |
| 20210529 | 20174512 | 0 | 53.25 | null | 2021-11-27 | 2021-11-27 | Docetaxel | 02 | null | DOCETAXEL | 101223355 |
| 20210640 | 20174513 | 1.62 | 75 | Palliative (P) | 2019-07-26 | 2019-07-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101303690 |
| 20210651 | 20174514 | 1.59 | 89.1 | null | 2021-07-31 | 2022-02-27 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100340470 |
| 20210665 | 20174515 | 1.68 | 70 | Palliative (P) | 2021-05-04 | 2021-12-20 | Docetaxel | 02 | N | DOCETAXEL | 101832039 |
| 20210686 | 20174516 | 1.87 | 65 | Palliative (P) | 2019-06-26 | 2019-06-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100199083 |
| 20210707 | 20174517 | 1.79 | 77.9 | Palliative (P) | 2019-08-01 | 2019-11-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100535174 |
| 20210709 | 20174518 | 1.84 | 56.1 | Palliative (P) | 2017-03-18 | 2017-03-21 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100267212 |
| 20210726 | 20174519 | 1.7 | 38.7 | Palliative (P) | 2021-08-16 | 2021-08-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101046629 |
| 20210731 | 20174520 | 1.6 | 50.4 | Palliative (P) | 2019-02-23 | 2019-04-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100427964 |
| 20210782 | 20174521 | 1.61 | 79.8 | null | 2019-10-03 | 2019-12-21 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101092898 |
| 20210787 | 20174522 | 1.81 | 43.3 | Palliative (P) | 2022-02-26 | 2022-03-12 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100180458 |
| 20210800 | 20174523 | 1.66 | 61.5 | Palliative (P) | 2017-04-27 | 2017-06-23 | CETUXIMAB + IRINOTECAN + FLUOROURACIL | 02 | N | CAPECITABINE + GEMCITABINE | 100506056 |
| 20210821 | 20174524 | 1.66 | 70.4 | Palliative (P) | 2019-04-19 | 2019-04-22 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101226094 |
| 20210842 | 20174525 | 1.66 | 87.5 | Palliative (P) | 2018-11-19 | 2018-12-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101157678 |
| 20210898 | 20174526 | 1.68 | 57.3 | null | 2019-10-09 | 2019-10-21 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101528039 |
| 20210912 | 20174527 | 1.76 | 55 | Palliative (P) | 2021-12-15 | 2022-01-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101833695 |
| 20210930 | 20174528 | 1.55 | 77.6 | Palliative (P) | null | 2016-08-02 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101413441 |
| 20210999 | 20174529 | 1.85 | 72 | Adjuvant (A) | 2018-01-26 | 2018-06-11 | Docetaxel | 02 | N | DOCETAXEL | 100573211 |
| 20211029 | 20174530 | 1.7 | 87.9 | null | 2021-02-07 | 2021-05-12 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100425386 |
| 20211048 | 20174531 | 1.71 | 74.4 | Palliative (P) | 2022-03-10 | 2022-03-22 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101722776 |
| 20211058 | 20174532 | 1.68 | 88.9 | Palliative (P) | 2021-02-15 | 2021-02-21 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101618383 |
| 20211076 | 20174533 | 1.63 | 64.3 | Adjuvant (A) | 2018-07-13 | 2018-08-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100136136 |
| 20211127 | 20174534 | 1.74 | 50.8 | null | 2022-01-14 | 2022-04-16 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100870910 |
| 20211128 | 20174535 | 1.84 | 81.75 | null | 2021-09-09 | 2021-09-19 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100056162 |
| 20211155 | 20174536 | 1.55 | 95 | Palliative (P) | 2019-01-05 | 2019-01-19 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101742599 |
| 20211159 | 20174537 | 1.86 | 105.4 | Palliative (P) | 2021-09-22 | 2021-09-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101609075 |
| 20211185 | 20174539 | 1.55 | 58.2 | Palliative (P) | 2021-02-08 | 2021-02-08 | Docetaxel | 02 | N | DOCETAXEL | 101339493 |
| 20211186 | 20174540 | 1.69 | 89 | Palliative (P) | 2017-01-18 | 2017-02-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101099748 |
| 20211189 | 20174541 | 1.7 | 91 | Adjuvant (A) | 2017-09-27 | 2017-10-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100986067 |
| 20211233 | 20174542 | 1.76 | 93.5 | null | 2018-09-30 | 2018-10-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101722617 |
| 20211264 | 20174544 | 0 | 67.1 | Adjuvant (A) | 2019-05-23 | 2019-06-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100293766 |
| 20211313 | 20174545 | 0 | 62.9 | null | 2018-04-10 | 2018-05-11 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100279552 |
| 20211318 | 20174546 | 1.61 | 77.9 | Palliative (P) | 2018-09-14 | 2018-12-13 | Docetaxel | 02 | N | DOCETAXEL | 101499753 |
| 20211343 | 20174547 | 1.68 | 60.2 | null | 2021-01-02 | 2021-02-21 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101228011 |
| 20211346 | 20174548 | 1.66 | 74.4 | null | 2018-02-15 | 2018-11-25 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100737897 |
| 20211363 | 20174549 | 1.55 | 59.7 | Palliative (P) | 2017-09-27 | 2018-05-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101028035 |
| 20211423 | 20174550 | 1.76 | 94.2 | Palliative (P) | 2022-02-04 | 2022-02-17 | Cetuximab + FOLFIRI cycle1 | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100295729 |
| 20211431 | 20174551 | 1.6 | 78 | null | 2020-07-23 | 2020-08-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101378731 |